Guardant Health, Inc.
GHNasdaq
$155.87
↑ +0.6%Jul 17 close · end-of-day
Price
1Y↑ +226.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$20.5B
Enterprise Value
$20.9B
P/E
—
P/S
18.9
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
-1.2%
Dividend Yield
—
Revenue (TTM)
$1.1B
Net Income (TTM)
-$433.2M
Free Cash Flow (TTM)
-$237.1M
Gross Margin
—
Operating Margin
-41.4%
Net Margin
-40.1%
ROE
239.3%
ROIC
-161.0%
Debt / Equity
-8.3
Net Cash
-$400.7M
Return 1Y
+229.7%
Company profile
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, LDT, CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible. Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients.
- CEO
- Helmy Eltoukhy
- Sector
- Services
- Industry
- Healthcare
- Employees
- 1,790
- Headquarters
- California
- Website
- guardanthealth.com
Management & directors
- Bell Michael BrianChief Financial Officer
- Chudova DaryaChief Technology Officer
- Eltoukhy HelmyCo-Chief Executive Officer
- Freeman ChrisChief Commercial Officer
- Kalia KumudChief Information Officer
- Monroe Terilyn J.Chief People Officer
- Saia John G.Chief Legal Officer
- Talasaz AmiraliCo-Chief Executive Officer
- Eagle CraigChief Medical Officer
Roles derived from SEC Form 4 filings.
Earnings
GH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$301.7M↑ +48.3%
Diluted EPS-$0.85↑ +10.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $286.7M | $373.7M | $449.5M | $563.9M | $739.0M | $982.0M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$254.9M | -$411.0M | -$544.4M | -$564.7M | -$443.6M | -$437.2M |
| Net income | — | -$384.8M | -$654.6M | -$479.4M | -$436.4M | -$416.3M |
| Diluted EPS | -$2.60 | -$4.00 | -$6.41 | -$4.28 | -$3.56 | -$3.32 |
| Operating cash flow | -$103.9M | -$209.0M | -$309.5M | -$325.0M | -$239.9M | -$184.8M |
| Free cash flow | -$140.1M | -$284.1M | -$386.9M | -$345.5M | -$274.9M | -$233.1M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -88.9% | -110.0% | -121.1% | -100.1% | -60.0% | -44.5% |
| Net margin | — | -103.0% | -145.6% | -85.0% | -59.1% | -42.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $177.2M | $191.5M | $201.8M | $203.5M | $232.1M | $265.2M | $281.3M | $301.7M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$100.6M | -$117.3M | -$126.0M | -$111.0M | -$106.4M | -$99.0M | -$120.8M | -$121.3M |
| Net income | -$102.6M | -$107.8M | -$111.0M | -$95.2M | -$99.9M | -$92.7M | -$128.5M | -$112.1M |
| Diluted EPS | -$0.84 | -$0.88 | -$0.90 | -$0.77 | -$0.80 | -$0.74 | -$1.01 | -$0.85 |
| Operating cash flow | -$94.0M | -$51.1M | -$64.5M | -$62.7M | -$60.3M | -$35.4M | -$26.4M | -$65.6M |
| Free cash flow | -$99.1M | -$55.3M | -$83.4M | -$67.1M | -$65.9M | -$45.8M | -$54.2M | -$71.2M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -56.8% | -61.3% | -62.4% | -54.6% | -45.9% | -37.3% | -43.0% | -40.2% |
| Net margin | -57.9% | -56.3% | -55.0% | -46.8% | -43.0% | -35.0% | -45.7% | -37.2% |
Company news
Jul 13, 2026
Jul 9, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-16 | Tariq Musa | Sale | 116 | $163.29 | $18,941.64 | filing |
| 2026-07-15 | Tariq Musa | Option exercise | 250 | $0.00 | $0.00 | filing |
| 2026-07-01 | Talasaz AmirAli· Co-Chief Executive Officer | Tax withholding | 17,086 | $170.77 | $2.9M | filing |
| 2026-07-01 | Eltoukhy Helmy· Co-Chief Executive Officer | Tax withholding | 17,086 | $170.77 | $2.9M | filing |
| 2026-07-01 | Chudova Darya· Chief Technology Officer | Tax withholding | 4,318 | $170.77 | $737,384.86 | filing |
| 2026-07-01 | Bell Michael Brian· Chief Financial Officer | Tax withholding | 3,914 | $170.77 | $668,393.78 | filing |
| 2026-07-01 | Saia John G.· Chief Legal Officer | Tax withholding | 3,707 | $170.77 | $633,044.39 | filing |
| 2026-07-01 | Freeman Chris· Chief Commercial Officer | Tax withholding | 3,141 | $170.77 | $536,388.57 | filing |
| 2026-07-01 | Kalia Kumud· Chief Information Officer | Tax withholding | 3,066 | $170.77 | $523,580.82 | filing |
| 2026-07-01 | Monroe Terilyn J.· Chief People Officer | Tax withholding | 2,099 | $170.77 | $358,446.23 | filing |
| 2026-07-01 | Kalia Kumud· Chief Information Officer | Option exercise | 1,994 | $0.00 | $0.00 | filing |
| 2026-07-01 | Kalia Kumud· Chief Information Officer | Option exercise | 1,361 | $0.00 | $0.00 | filing |
| 2026-07-01 | Freeman Chris· Chief Commercial Officer | Option exercise | 1,928 | $0.00 | $0.00 | filing |
| 2026-07-01 | Freeman Chris· Chief Commercial Officer | Option exercise | 1,667 | $0.00 | $0.00 | filing |
| 2026-07-01 | Freeman Chris· Chief Commercial Officer | Option exercise | 2,526 | $0.00 | $0.00 | filing |
| 2026-07-01 | Freeman Chris· Chief Commercial Officer | Option exercise | 1,293 | $0.00 | $0.00 | filing |
| 2026-07-01 | Chudova Darya· Chief Technology Officer | Option exercise | 1,339 | $0.00 | $0.00 | filing |
| 2026-07-01 | Chudova Darya· Chief Technology Officer | Option exercise | 1,667 | $0.00 | $0.00 | filing |
| 2026-07-01 | Chudova Darya· Chief Technology Officer | Option exercise | 3,324 | $0.00 | $0.00 | filing |
| 2026-07-01 | Chudova Darya· Chief Technology Officer | Option exercise | 1,700 | $0.00 | $0.00 | filing |
| 2026-07-01 | Bell Michael Brian· Chief Financial Officer | Option exercise | 2,084 | $0.00 | $0.00 | filing |
| 2026-07-01 | Bell Michael Brian· Chief Financial Officer | Option exercise | 3,324 | $0.00 | $0.00 | filing |
| 2026-07-01 | Bell Michael Brian· Chief Financial Officer | Option exercise | 1,870 | $0.00 | $0.00 | filing |
| 2026-07-01 | Eltoukhy Helmy· Co-Chief Executive Officer | Option exercise | 23,997 | $0.00 | $0.00 | filing |
| 2026-07-01 | Eltoukhy Helmy· Co-Chief Executive Officer | Option exercise | 9,715 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.